芳香化酶抑制剂是雌激素受体 (ER)和 (或 )孕激素受体(PR)阳性、绝经后乳腺癌患者主要治疗手段之一 ,但不适用于绝经前患者。我们针对绝经前患者 ,设计采用了药物卵巢去势加用第三代芳香化酶抑制剂方案 ,治疗了 1例Herceptin、泰索帝、表阿霉素治疗无效的乳腺癌患者 ,获得较好 Aromatase inhibitors are among the major treatments for estrogen receptor (ER) and / or progesterone receptor (PR) -positive breast cancer in postmenopausal women, but are not suitable for premenopausal patients. For the pre-menopausal patients, we designed the ovariectomized ovary plus third-generation aromatase inhibitor regimen to treat one case of breast cancer with ineffective treatment of Herceptin, taxotere and epirubicin.